• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.03% Nasdaq Up 1.29%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    9.15 Up 0.48(5.54%) May 1, 4:00PM EDT
    |After Hours : 9.13 Down 0.02 (0.22%) May 1, 7:37PM EDT
    Add to Portfolio
    Prev Close:8.67
    Open:8.77
    Bid:9.00 x 3500
    Ask:9.13 x 100
    1y Target Est:8.68
    Beta:1.17
    Next Earnings Date: 7-May-15ARIA Earnings announcement
    Day's Range:8.67 - 9.16
    52wk Range:4.90 - 9.89
    Volume:7,427,027
    Avg Vol (3m):6,292,060
    Market Cap:1.72B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 5.54%1.72B
    NVSUp 1.52%247.90B
    PFEUp 0.44%209.26B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.03
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback